New
HealthMore in Health→
Ebola Vaccine Trial Begins in DR Congo as Bundibugyo Outbreak Grows
Key Takeaways
- The Tumaini Ebola vaccine trial began with first vaccinations in Bunia, DR Congo.
- Ervebo is being tested for cross-protection against Bundibugyo ebolavirus.
- Oxford and Moderna candidates designed for Bundibugyo are expected to enter the trial.
DE
DT Editorial Team··via medicalxpress.com